PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

"Every Brilliant Thing”, the interactive one-person play with a suicidality theme now making its West End debut, reduced suicide-associated stigma among university students who attended, even up to 30

2025-08-14
(Press-News.org) "Every Brilliant Thing”, the interactive one-person play with a suicidality theme now making its West End debut, reduced suicide-associated stigma among university students who attended, even up to 30 days later.

+++

Article URL: https://plos.io/411ECQu

Article Title: A performing arts intervention to decrease suicide stigma on campus: A three time point assessment of “Every Brilliant Thing”

Author Countries: United States

Funding: The authors received no specific funding for this work.

END


ELSE PRESS RELEASES FROM THIS DATE:

Climate models reveal human influence behind stalled pacific cycle

2025-08-14
A new CU Boulder-led study has revealed that recent changes in North Pacific Ocean temperatures—long believed to be the result of natural variability—are in fact being driven by human-generated greenhouse gas and industrial aerosol emissions. These oceanic shifts are directly linked to the prolonged megadrought gripping the American Southwest, and this research published August 13th in Nature suggests it may not ease for another 30 years. “Our results show that the drought and ocean patterns we’re seeing today are not just natural fluctuations—they’re largely driven by human activity,” ...

Laying the foundation for gene editing for inherited progressive deafness in adults, DFNA41

2025-08-14
Zheng-Yi Chen, DPhil, associate scientist at the Eaton-Peabody Laboratories, and Ines and Fredrick Yeatts Chair in Otolaryngology, at Mass Eye and Ear, is the senior and co-corresponding author of a paper published in the Journal of Clinical Investigation, “Single Dose Genome Editing Therapy Rescues Auditory and Vestibular Functions in Adult Mice with DFNA41 Deafness.” Q: How would you summarize your study for a lay audience? This study provides an example of a successful use of gene editing technology to treat a mouse model of human genetic hearing loss. We developed a one-time, gene editing ...

Monell Center researchers present latest findings at International Meeting on Consumer Sensory Science

2025-08-14
Monell Center Researchers Present Latest Findings at International Meeting On Consumer Sensory Science Coinciding with the 2025 Philadelphia-based conference, Monell - the first independent nonprofit dedicated to smell and taste research - hosts academic, industry partners for visits, collaborations  PHILADELPHIA (Aug 14, 2025) – Scientists from the Monell Chemical Senses Center will present their research at the 16th Pangborn Sensory Science Symposium, “Connecting Senses and Minds,” August 17-21, 2025 ...

AFAR receives NIH award renewal totaling more than $5.7 million for the Nathan Shock Centers Coordinating Center

2025-08-14
NEW YORK — The American Federation for Aging Research (AFAR) has received a five-year renewal award totaling $5,722,435 from the National Institute on Aging (NIA), part of the National Institutes of Health (NIH), to continue and expand the Nathan Shock Centers Coordinating Center (NSC3). The NSC3 coordinates the activities of the 8 Nathan Shock Centers (NSC) of Excellence in the Basic Biology of Aging, which provide expert resources to expand basic research into the biology of aging. The NSCs began in 1995 in honor of ...

Brain-computer interface could decode inner speech in real time

2025-08-14
Scientists have pinpointed brain activity related to inner speech—the silent monologue in people’s heads—and successfully decoded it on command with up to 74% accuracy. Publishing August 14 in the Cell Press journal Cell, their findings could help people who are unable to audibly speak communicate more easily using brain-computer interface (BCI) technologies that begin translating inner thoughts when a participant says a password inside their head.  “This is the first time ...

Cancer drug eliminates aggressive cancers in clinical trial

2025-08-14
Over the past 20 years, a class of cancer drugs called CD40 agonist antibodies have shown great promise—and induced great disappointment. While effective at activating the immune system to kill cancer cells in animal models, the drugs had limited impact on patients in clinical trials and caused dangerously systemic inflammatory responses, low platelet counts, and liver toxicity, among other adverse reactions—even at a low dose. But in 2018, the lab of Rockefeller University’s Jeffrey V. Ravetch demonstrated it could engineer an enhanced CD40 ...

Ancient cephalopod, new insight: Nautilus reveals unexpected sex chromosome system

2025-08-14
Nautiloids—a lineage of ancient, externally-shelled cephalopods that diverged from their octopus and squid relatives over 400 million years ago—once dominated our oceans. Today, this living fossil is restricted to a handful of species in the Southern Indo-Pacific, making it one of the few marine invertebrates listed under CITES appendix II of species in need of protection from over-exploitation.. Although no one had previously investigated sex determination systems in cephalopods, recent research suggested a ZZ/Z0 ...

MIT researchers use generative AI to design compounds that can kill drug-resistant bacteria

2025-08-14
CAMBRIDGE, MA -- With help from artificial intelligence, MIT researchers have designed novel antibiotics that can combat two hard-to-treat infections: drug-resistant Neisseria gonorrhoeae and multi-drug-resistant Staphylococcus aureus (MRSA). Using generative AI algorithms, the research team designed more than 36 million possible compounds and computationally screened them for antimicrobial properties. The top candidates they discovered are structurally distinct from any existing antibiotics, and they appear to work by novel ...

Alzheimer’s disease pathology and potential treatment targets identified in brain organoids

2025-08-14
Alzheimer's disease (AD) is the most common neurodegenerative disease in older people, affecting up to 1 in 20 individuals aged 65 and above. In addition to environmental and lifestyle factors, genetic mutations can predispose an individual to AD and some rare forms of inherited “familial” AD (fAD) are caused by known genetic mutations, with these affected individuals developing AD with high probability and at relatively young age. In most cases, AD is diagnosed at advanced stages, but pathological alterations in brain cells may ...

1 in 3 US adults unaware of connection between HPV and cancers

2025-08-14
The human papillomavirus (HPV) can cause six types of cancer.  It’s responsible for almost all cervical cancer cases. HPV now causes the majority of oropharyngeal (throat) cancers. It can also cause anal, vaginal, vulvar and penile cancers.   Yet new analysis from researchers at MUSC Hollings Cancer Center shows that most people are unaware of the connection between HPV and all of these cancers.   That awareness is critical, said lead researcher Kalyani Sonawane, Ph.D., because it informs people’s decisions ...

LAST 30 PRESS RELEASES:

ORC2 regulation of human gene expression shows unexpected breadth and scale

Researchers track how iron deficiency disrupts photosynthesis in crucial ocean algae

A Mount Sinai-Led team creates model for understanding how the brain’s decision-making is impacted in psychiatric disorders

A new way to study omega fatty acids

Targeting ferroptosis in cancer stem cells: A promising approach to enhance cancer treatment

As the atmosphere changes, so will its response to geomagnetic storms

First transfer of behavior between species through single gene manipulation

A new network could help predict health problems in your pup

Connecting biofuel and conservation policies

Deep learning model successfully predicted ignition in inertial confinement fusion experiment

Maternal antibodies in breast milk regulate early immune responses in mouse gut

Densely planted maize communicates with neighboring plants to defend against pests

Paper: Decarbonize agriculture by expanding policies aimed at low-carbon biofuels

New tech speeds up AI training for drug discovery/disease research

Researchers synthesize a new allotrope of carbon

Scientists hack microbes to identify environmental sources of methane

New high blood pressure guideline emphasizes prevention, early treatment to reduce CVD risk

"Every Brilliant Thing”, the interactive one-person play with a suicidality theme now making its West End debut, reduced suicide-associated stigma among university students who attended, even up to 30

Climate models reveal human influence behind stalled pacific cycle

Laying the foundation for gene editing for inherited progressive deafness in adults, DFNA41

Monell Center researchers present latest findings at International Meeting on Consumer Sensory Science

AFAR receives NIH award renewal totaling more than $5.7 million for the Nathan Shock Centers Coordinating Center

Brain-computer interface could decode inner speech in real time

Cancer drug eliminates aggressive cancers in clinical trial

Ancient cephalopod, new insight: Nautilus reveals unexpected sex chromosome system

MIT researchers use generative AI to design compounds that can kill drug-resistant bacteria

Alzheimer’s disease pathology and potential treatment targets identified in brain organoids

1 in 3 US adults unaware of connection between HPV and cancers

State-level public awareness of HPV, HPV vaccine, and association with cancer

Mayo Clinic researchers discover the immune system's 'fountain of youth'

[Press-News.org] "Every Brilliant Thing”, the interactive one-person play with a suicidality theme now making its West End debut, reduced suicide-associated stigma among university students who attended, even up to 30